|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.970 CNY | +0.40% |
|
+3.54% | -2.93% |
| 03/06 | Jointown Pharmaceutical Unit Gets Nod to Market Allergy Symptoms Treatment | MT |
| 27/05 | Jointown Pharma Unit Passes China Generic Drug Evaluation | MT |
| Capitalization | 2.48TCr 365.84Cr 316.82Cr 290.7Cr 273.5Cr 509.41Cr 35TCr 517.38Cr 3.46TCr 1.34TCr 17TCr 1.37TCr 1.34TCr 59TCr | P/E ratio 2026 * |
11.3x | P/E ratio 2027 * | 9.64x |
|---|---|---|---|---|---|
| Enterprise value | 2.07TCr 305.98Cr 264.98Cr 243.13Cr 228.75Cr 426.05Cr 29TCr 432.71Cr 2.89TCr 1.12TCr 14TCr 1.15TCr 1.12TCr 49TCr | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
3.89% | Yield 2027 * | 4.48% |
| 1 day | +0.40% | ||
| 1 week | +3.54% | ||
| Current month | +3.54% | ||
| 1 month | -2.74% | ||
| 3 months | -5.51% | ||
| 6 months | -2.74% | ||
| Current year | -2.93% |
| 1 week | 4.79 |  | 5.02 |
| 1 month | 4.63 | | 5.09 |
| Current year | 4.63 | | 5.84 |
| 1 year | 4.63 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei He
CEO | Chief Executive Officer | 40 | 23/04/2022 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 15/11/2023 |
Xi Zhang
IRC | Investor Relations Contact | - | 23/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 16/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 05/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 01/07/2012 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | +3.54% | -7.10% | -18.20% | 365.84Cr | |
| +2.47% | +4.47% | +8.81% | +99.42% | 9.32TCr | |
| +1.97% | +4.53% | +32.96% | +143.91% | 4.82TCr | |
| +0.34% | -0.68% | -6.41% | +276.77% | 2.37TCr | |
| +0.99% | -1.33% | -11.87% | -29.49% | 805Cr | |
| +2.08% | -2.07% | -34.03% | -29.43% | 735.76Cr | |
| +0.35% | +1.71% | -7.87% | -34.81% | 685.46Cr | |
| +1.36% | +3.18% | +16.67% | +18.83% | 663.57Cr | |
| +0.96% | +0.90% | -2.21% | +16.00% | 527.33Cr | |
| +1.06% | -2.71% | +16.52% | +16.55% | 341.35Cr | |
| Average | +1.20% | +0.13% | +0.55% | +45.96% | 2.06TCr | |
| Weighted average by Cap. | +1.83% | +0.18% | +9.62% | +107.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17TCr 2.51TCr 2.18TCr 2TCr 1.88TCr 3.5TCr 2,39400Cr 3.55TCr 24TCr 9.24TCr 1,15800Cr 9.43TCr 9.23TCr 4,02700Cr | 18TCr 2.64TCr 2.29TCr 2.1TCr 1.98TCr 3.68TCr 2,52000Cr 3.74TCr 25TCr 9.72TCr 1,21900Cr 9.93TCr 9.71TCr 4,23900Cr |
| Net income | 221.62Cr 33Cr 28Cr 26Cr 24Cr 46Cr 3.12TCr 46Cr 309Cr 120.26Cr 1.51TCr 122.84Cr 120.17Cr 5.24TCr | 260.1Cr 38Cr 33Cr 31Cr 29Cr 53Cr 3.66TCr 54Cr 362.66Cr 141.14Cr 1.77TCr 144.17Cr 141.04Cr 6.15TCr |
| Net Debt | -405.54Cr -60Cr -52Cr -48Cr -45Cr -83Cr -5.7TCr -85Cr -565.43Cr -220.06Cr -2.76TCr -224.79Cr -219.89Cr -9.59TCr | -531.76Cr -78Cr -68Cr -62Cr -59Cr -109.3Cr -7.48TCr -111.01Cr -741.42Cr -288.55Cr -3.62TCr -294.75Cr -288.34Cr -13TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 4.970 ¥ | +0.40% | 2,99,60,420 |
| 04/26/04 | 4.950 ¥ | +1.23% | 3,06,30,220 |
| 03/26/03 | 4.890 ¥ | 0.00% | 2,49,89,050 |
| 02/26/02 | 4.890 ¥ | -0.20% | 2,42,49,170 |
| 01/26/01 | 4.900 ¥ | +2.08% | 2,76,19,190 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition